[EN] T-CELL LYMPHOMA TREATMENTS<br/>[FR] TRAITEMENTS DE LYMPHOME T
申请人:HOPE CITY
公开号:WO2018232274A1
公开(公告)日:2018-12-20
Described herein are methods for treating T-cell lymphoma in a subject in need thereof, comprising administering to the subject in need thereof, an ETP compound. Also described herein are pharmaceutical compositions and compositions for use that include such ETP compound.
Well-Designed Phosphine–Urea Ligand for Highly Diastereo- and Enantioselective 1,3-Dipolar Cycloaddition of Methacrylonitrile: A Combined Experimental and Theoretical Study
A novel chiral phosphine-urea bifunctional ligand has been developed for Cu-catalyzed asymmetric 1,3-dipolar cycloaddition of iminoesters with methacrylonitrile, a long-standing challenging substrate in asymmetric catalysis. Distortion-interaction energy analysis based on density functional theory (DFT) calculations reveals that the distortion energy plays an important role in the observed enantioselectivity
Provided herein, inter alia, is the synthesis of ETP derivatives. The uses of the ETP derivatives described herein include treatment of cancer.
本文提供了ETP衍生物的合成。此处描述的ETP衍生物的用途包括治疗癌症。
Catalytic Asymmetric exo′-Selective [3+2] Cycloaddition of Iminoesters with Nitroalkenes
作者:Takayoshi Arai、Naota Yokoyama、Asami Mishiro、Hiroyasu Sato
DOI:10.1002/anie.201004098
日期:2010.10.18
Under control: A chiral imidazoline–aminophenol/Ni(OAc)2 complex promotes the first catalyticasymmetric exo′‐selective [3+2] cycloaddition of iminoesters and nitroalkenes. Thermodynamic control over the stepwise Michael/Mannich cyclization steps gives the adducts in up to 99 % ee.
Design, Synthesis, and Biological Evaluation of Chemically and Biologically Diverse Pyrroquinoline Pseudo Natural Products
作者:Jie Liu、Gregor S. Cremosnik、Felix Otte、Axel Pahl、Sonja Sievers、Carsten Strohmann、Herbert Waldmann
DOI:10.1002/anie.202013731
日期:2021.2.23
Naturalproduct (NP) structures are a rich source of inspiration for the discovery of new biologically relevant chemical matter. In naturalproduct inspired pseudo‐NPs, NP‐derived fragments are combined de novo in unprecedented arrangements. Described here is the design and synthesis of a 155‐member pyrroquinoline pseudo‐NP collection in which fragments characteristic of the tetrahydroquinoline and